Supriya Lifescience

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue107.70144.23134.94142.57143.14
Expenses95.0690.9492.31112.78103.04
EBITDA16.6157.0147.1534.2244.55
EBIT13.6554.0043.2030.2440.59
Profit Before Tax12.6553.2942.6429.7740.10
Net Profit9.5238.2328.5123.8829.79
Financial Ratios
Operating Profit Margin15.80%40.07%35.71%24.43%31.81%
Net Profit Margin9.05%26.87%21.60%17.04%21.27%
Earning Per Share (Diluted)1.184.753.542.973.70
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.9.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ